Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs iShares Core High Dividend ETF (HDV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs iShares Core High Dividend ETF — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while iShares Core High Dividend ETF trades at $29.8 (market cap $15.36B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 2× iShares Core High Dividend ETF's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while iShares Core High Dividend ETF pays none. Which is the better fit depends on your goals.
| GEHC | HDV | |
|---|---|---|
Market Cap | $30.93B | $15.36B |
Volume | 5,033,451 | 3,407,621 |
Sector | Health | — |
52-Week High | $88.16 | $29.93 |
52-Week Low | $59.48 | $23.64 |
Enterprise Value | $39.39B | — |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 118 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
HDV (iShares Core High Dividend ETF) trades at $29.15, up 0.28% with a bullish technical signal from moving averages and oscillators. The ETF recently underwent a major sector rebalance, reducing healthcare exposure while increasing energy, staples, and utilities. Current RSI levels suggest mild overbought conditions, with support and resistance clustered around $29.
The outlook remains positive given the ETF's focus on high dividend-paying stocks during a period of market rotation toward income strategies. Key risks include sector concentration with 62% in three sectors and potential yield compression if interest rates continue rising. The 3% yield provides income appeal but requires monitoring of underlying holdings' dividend sustainability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About iShares Core High Dividend ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is comprised of qualified income paying securities that are screened for superior company quality and financial health as determined by Morningstar, Inc.'s proprietary index methodology. The fund is non-diversified.
Read more on HDV →
